MLL2 mosaic mutations and intragenic deletion-duplications in patients with Kabuki syndrome

  • S. Banka
  • , E. Howard
  • , S. Bunstone
  • , K. E. Chandler
  • , B. Kerr
  • , K. Lachlan
  • , S. Mckee
  • , S. G. Mehta
  • , A. L T Tavares
  • , J. Tolmie
  • , D. Donnai

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Kabuki syndrome (KS) is a rare multi-system disorder that can result in a variety of congenital malformations, typical dysmorphism and variable learning disability. It is caused by MLL2 point mutations in the majority of the cases and, rarely by deletions involving KDM6A. Nearly one third of cases remain unsolved. Here, we expand the known genetic basis of KS by presenting five typical patients with the condition, all of whom have novel MLL2 mutation types- two patients with mosaic small deletions, one with a mosaic whole-gene deletion, one with a multi-exon deletion and one with an intragenic multi-exon duplication. We recommend MLL2 dosage studies for all patients with typical KS, where traditional Sanger sequencing fails to identify mutations. The prevalence of such MLL2 mutations in KS may be comparable with deletions involving KDM6A. These findings may be helpful in understanding the mutational mechanism of MLL2 and the disease mechanism of KS. © 2012 John Wiley & Sons A/S.
    Original languageEnglish
    Pages (from-to)467-471
    Number of pages4
    JournalClinical Genetics
    Volume83
    Issue number5
    DOIs
    Publication statusPublished - May 2013

    Keywords

    • Intragenic deletion duplication
    • Kabuki syndrome
    • KDM6A
    • MLL2
    • Mosaic

    Fingerprint

    Dive into the research topics of 'MLL2 mosaic mutations and intragenic deletion-duplications in patients with Kabuki syndrome'. Together they form a unique fingerprint.

    Cite this